Fri, Dec 26, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Understanding differing dimensions of risk is crucial say Roundtable participants

Wednesday, January 23, 2013

amb
Daniel Ades
By Beverly Chandler, Opalesque London:

Participants at the Opalesque Florida Roundtable, sponsored by Eurex and Wells Fargo Insurance Services, discussed the dimensions of risk in a portfolio, and how they are interlinked.

Daniel Ades, partner at Kawa Capital Management commented that the risk dimension is as fundamental to portfolio construction as risk/reward. "People have different perceptions of risk, and I believe it is helpful that investors are really aware and conscious about which of the three basic types of risk they are taking." For Ades, there are three basic risk dimensions: "Duration - how long you are going to hold the investment; liquidity - how liquid is it, and credit risk, which is how likely is a permanent loss of capital."

Ades believes that all investments include a particular equation between these three different forces, so each investment includes different nuances of these risks. "And if an investor is going further along the risk curve, they are taking more risk, also in the other two types of risk. So for us, the other area of friction when talking to prospective investors is often around risk. We sometimes see that investors don't realize the risk they are taking in the other two areas of risk, because they ha......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its